Mediating role of depression medication on association between Body Mass Index and cigarette smoking among US adults: Insights from the NHIS

Olanrewaju Onigbogi, Alperen Korkmaz, Kebba Kah, Emilee J Delbridge, Kolawole Okuyemi · 2026

Read Mediating role of depression medication on association between Body Mass Index and cigarette smoking among US adults: Insights from the NHIS by Olanrewaju Onigbogi, Alperen Korkmaz, Kebba Kah, Emilee J Delbridge, Kolawole Okuyemi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0351210.txt.

Description

Olanrewaju Onigbogi and four co-authors study how depression drugs link body weight and smoking in American adults. They used a 2023 national health survey. Their model asked whether taking drugs for depression helps explain smoking habits. They compared adults who were underweight, normal weight, overweight, or obese.

Use of depression drugs played the largest connecting role in underweight adults. It played the smallest role in obese adults. Underweight adults on such drugs were more likely to smoke than obese adults were. Obese adults on the drugs also showed raised odds of smoking, compared with underweight peers. The authors say weight group should be part of the picture. Clinicians should weigh it when they design quit-smoking support for people treated for depression.

Catalog record

CREATOROlanrewaju Onigbogi, Alperen Korkmaz, Kebba Kah, Emilee J Delbridge, Kolawole Okuyemi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29077
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0351210

Browse the full library · About the Tower of Babel